EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY 4.0

Weight Loss Improves Predicted 10‐Year MACE and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year

Abdelrahman M Elshakankiry iD, Gary R Hunter iD, Cátia Martins iD, Gordon Fisher iD, W Timothy Garvey iD, Carrie R Howell iD

Obesity · 2026

DOI: 10.1002/oby.70291 ↗

At a glance

Randomisierte kontrollierte Studie in Obesity, 2026. Written by Abdelrahman M Elshakankiry and 5 co-authors. Institution: Department of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama, USA. Major MEDLINE topics: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Overweight, Weight Loss. 42 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIH HHS, NIDDK NIH HHS, NCRR NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

This study aimed to quantify changes in predicted 10‐year risk for major adverse cardiovascular events (MACE) and type 2 diabetes (T2D) across weight loss, post–weight loss (Post‐WL), and 1‐year follow‐up and to determine whether trajectories varied by exercise modality.

Methods

Sedentary women with overweight (21–49 years) were randomized to Diet+Aerobic, Diet+Resistance, or Diet‐only and completed an 800 kcal/day diet until BMI < 25 kg m −2 . Predicted 10‐year MACE and T2D risks were calculated using cardiometabolic disease staging equations. Longitudinal changes and adherence effects were analyzed using fractional logit models fit with generalized estimating equations.

Results

Among 221 women (115 African American), mean BMI decreased from 28.3 to 23.9 kg m −2 , with regain to 25.8 at 1 year. MACE risk decreased from Baseline to Post‐WL and rebounded from Post‐WL to 1 year in all groups (all p < 0.001). Diet‐only achieved greater MACE reduction than Diet+Resistance ( p = 0.022). T2D risk decreased in all groups (all p < 0.001) but rebounded in Diet+Aerobic and Diet‐only. The Diet+Resistance group maintained a significant net reduction at 1 year ( p = 0.003). Follow‐up exercise adherence was associated with lower T2D risk rebound ( p = 0.024).

Conclusions

Weight loss reduced MACE and T2D risks, but both rebounded with weight regain. Resistance exercise may be beneficial in weight loss interventions to prevent progression to T2D. Trial Registration ClinicalTrials.gov identifier: NCT00067873

Subjects

MeSH terms (MEDLINE)

Cardiovascular DiseasesDiabetes Mellitus, Type 2OverweightWeight LossAdultFemaleHumansMiddle AgedBody Mass IndexDiet, ReducingExerciseFollow-Up StudiesObesityResistance TrainingRisk Factors

Author keywords

cardiometabolic riskresistance exercisetype 2 diabetesweight lossweight regain

Authors and institutions

  • Department of Nutrition Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Department of Human Studies, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Department of Medicine, Division of Internal General Medicine and Population Science, University of Alabama at Birmingham, Birmingham, Alabama, USA.

ORCID profiles: Abdelrahman M Elshakankiry, Gary R Hunter, Cátia Martins, Gordon Fisher, W Timothy Garvey, Carrie R Howell

Funding

  • NIH HHS
  • NIDDK NIH HHS
  • NCRR NIH HHS
  • National Institutes of Health

Cite

APA

Elshakankiry, A. M., Hunter, G. R., Martins, C., Fisher, G., Garvey, W. T., & Howell, C. R. (2026). Weight Loss Improves Predicted 10‐Year MACE and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year. Obesity. https://doi.org/10.1002/oby.70291

Vancouver

Elshakankiry AM, Hunter GR, Martins C, Fisher G, Garvey WT, Howell CR. Weight Loss Improves Predicted 10‐Year MACE and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year. Obesity. 2026. doi:10.1002/oby.70291

BibTeX
@article{Elshakankiry2026,
  author = {Elshakankiry, Abdelrahman M and Hunter, Gary R and Martins, Cátia and Fisher, Gordon and Garvey, W Timothy and Howell, Carrie R},
  title = {Weight Loss Improves Predicted 10‐Year MACE and Type 2 Diabetes Risk, but Benefits Partially Rebound at 1 Year},
  journal = {Obesity},
  year = {2026},
  doi = {10.1002/oby.70291}
}
Start for free →